A5082269089- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Hemodynamic Monitoring and Therapy
- Ultrasound in Clinical Applications
- Cardiac, Anesthesia and Surgical Outcomes
- Abdominal Surgery and Complications
- Chronic Disease Management Strategies
- Cardiac Arrest and Resuscitation
- Blood Pressure and Hypertension Studies
- Atrial Fibrillation Management and Outcomes
- Acute Myocardial Infarction Research
- Sepsis Diagnosis and Treatment
- Potassium and Related Disorders
- Cardiac pacing and defibrillation studies
- Dialysis and Renal Disease Management
- Respiratory Support and Mechanisms
- Cardiac Health and Mental Health
- COVID-19 Clinical Research Studies
- Cardiovascular and exercise physiology
- Chronic Kidney Disease and Diabetes
- Acute Kidney Injury Research
- Mechanical Circulatory Support Devices
- Case Reports on Hematomas
- Healthcare Systems and Technology
- IL-33, ST2, and ILC Pathways
Hospital Clínico Universitario Lozano Blesa
2016-2025
Instituto de Investigación Sanitaria Aragón
2015-2025
Universidad de Zaragoza
2018-2025
Hospital Municipal de Badalona
2014
Hospital Costa del Sol
2014
Hospital Infanta Margarita
2014
To evaluate whether the addition of hydrochlorothiazide (HCTZ) to intravenous furosemide is a safe and effective strategy for improving diuretic response in acute heart failure (AHF).A prospective, double-blind, placebo-controlled trial, including patients with AHF randomized receive HCTZ or placebo an regimen. The coprimary endpoints were changes body weight patient-reported dyspnoea 72 h after randomization. Secondary outcomes included metrics mortality/rehospitalizations at 30 90 days....
We sought to identify the comorbidities associated with heart failure (HF) in a non-selected cohort of patients, and its influence on mortality rehospitalization.Data were obtained from 'Registro de Insuficiencia Cardiaca' (RICA) Spanish Society Internal Medicine. The registry includes patients prospectively admitted Medicine units for acute HF. Variables included Charlson Index (ChI) collected analysed according age, gender, left ventricular ejection fraction (LVEF) Barthel Index. primary...
Hypertonic saline solution (HSS) plus intravenous (IV) loop diuretic appears to enhance the response in patients hospitalized for heart failure (HF). The efficacy and safety of this therapy ambulatory setting have not been evaluated. We aimed describe design baseline characteristics SALT-HF trial participants.
Background Lung ultrasound is feasible for assessing lung injury caused by coronavirus disease 2019 (COVID-19). However, the prognostic meaning and time-line changes of assessed in COVID-19 hospitalised patients are unknown. Methods Prospective cohort study designed to analyse value using a quantitative scale (lung Zaragoza (LUZ)-score) during first 72 h after admission. The primary end-point was in-hospital death and/or admission intensive care unit. Total length hospital stay, increase...
Although several biomarkers have shown correlation to prognosis in COVID-19 patients, their clinical value is limited because of lack specificity, suboptimal sensibility or poor dynamic behavior. We hypothesized that circulating soluble ST2 (sST2) could be associated a worse outcome COVID-19. In total, 152 patients admitted for confirmed were included prospective non-interventional, observational study. Blood samples drawn at admission, 48-72 h later and discharge. sST2 concentrations...
As part of the “2nd Training Conference on Heart Failure and Atrial Fibrillation for Residents”, held in Madrid November 2024, a collaborative initiative was launched to address most common practical challenges management heart failure (HF) daily practice. This document is result joint efforts residents from various hospitals nationwide, collaboration with senior physicians extensive HF expertise members Working Group Spanish Society Internal Medicine. Our aim provide useful tool that...
As part of the “2nd Training Conference on Heart Failure and Atrial Fibrillation for Residents”, held in Madrid November 2024, a collaborative initiative was launched to address most common practical challenges management heart failure (HF) daily practice. This document is result joint efforts residents from various hospitals nationwide, collaboration with senior physicians extensive HF expertise members Working Group Spanish Society Internal Medicine. Our aim provide useful tool that...
Background: Risk stratification of COVID-19 patients is fundamental to improving prognosis and selecting the right treatment. We hypothesized that a combination lung ultrasound (LUZ-score), biomarkers (sST2), clinical models (PANDEMYC score) could be useful improve risk stratification. Methods: This was prospective cohort study designed analyze prognostic value ultrasound, sST2, PANDEMYC score in patients. The primary endpoint in-hospital death and/or admission intensive care unit. total...
Increased intra-abdominal pressure (IAP) is now considered a potential contributor to organ damage and disease progression in acute heart failure (AHF). In this work, we aimed determine if antigen carbohydrate 125 (CA125) associated with IAP identify cutpoint of CA125 useful for ruling out hypertension (defined as ≥ 12 mmHg). We prospectively evaluated cohort 53 patients admitted AHF which was measured within the first 24-h admission. The mean age 80 ± 8 years, 31 (58.5%) were female, had...